ERAP1 and autoimmune disease: In a comprehensive review published in 2022, Liu Shuang et al. explored the relationship between ERAP1 polymorphisms and autoimmune diseases, offering insights into how these variations may impact the development of new medications targeting both wild-type and mutant proteins with different polymorphisms [19].